Conatus Pharmaceuticals Inc. was a big mover last session, as its shares rose almost 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 64% in the past one-month time frame.

The company has seen one positive estimate revision in the past 30 days, its Zacks Consensus Estimate moved higher over the same time frame, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Conatus currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is positive.

Conatus Pharmaceuticals Inc. Price

 

Conatus Pharmaceuticals Inc. Price | Conatus Pharmaceuticals Inc. Quote

A better-ranked stock in the Medical - Products space is ZELTIQ Aesthetics, Inc. , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is CNAT going up? Or down? Predict to see what others think: Up or Down

Looking for Ideas with Even Greater Upside?     

Most of Zacks’ investment ideas are short-term, directly based on our proven 1 to 3 month indicator. In addition, I invite you to consider our long-term opportunities. These rare trades look to start fast with strong Zacks Ranks, but carry through with double and triple-digit profit potential. Starting now, you can look inside our home run, value, and stocks under $10 portfolios, plus more.  
Click here for a peek at this private information>>